Answers are grounded in this paper and cite their sources.
Case report explores the relationship between pityriasis lichenoides chronica and multiple myeloma treatment, indicating skin reactions may arise from immune modulation.
Pityriasis lichenoides chronica (PLC) is a rare chronic inflammatory skin disorder typically affecting children and young adults, but it can occasionally manifest in older adults, especially those with underlying systemic diseases like multiple myeloma (MM). This case report describes a 66-year-old male with a 7-month history of MM, who developed pruritic, erythematous plaques with characteristic micaceous scaling indicative of PLC. The patient was undergoing treatment with the VRD regimen, consisting of bortezomib, lenalidomide, and dexamethasone, which are known for their immune-modulating effects. These medications, particularly bortezomib and lenalidomide, have been associated with drug-induced inflammatory skin reactions, potentially triggering or exacerbating PLC. In addition to MM, the patient’s comorbid conditions – diabetes mellitus and hypertension – may have further contributed to immune dysregulation, increasing susceptibility to PLC. The Naranjo adverse drug reaction probability scale indicated a score suggesting a possible drug-induced etiology for the skin condition. The patient was treated with narrowband ultraviolet B phototherapy, a well-established modality for managing PLC, with good clinical response. This case underscores the importance of considering PLC in older patients with MM undergoing immunomodulatory treatments. It highlights the need for careful dermatologic monitoring, particularly in those receiving potent cancer therapies that modulate the immune system. Further investigation is warranted to better understand the interaction between systemic malignancies, their treatments, and PLC in immunocompromised patients.
No takes yet. Share an insight, caveat, or question.
Bindu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: